Search Results for 'Biomarkers'

by Bianca Castelli and Shima Shapoori

Researchers have long suspected that taking a number of prescription medications concurrently, otherwise known as polypharmacy, is a leading cause of therapeutic non-compliance among patients.

The statement continued: “It is important to note that this testing is a first step to diagnosis. The National Prostate Cancer GP referral guidelines state that patients with an abnormal PSA result should have a repeat PSA at six weeks. A clinical prostate assessment to include a digital rectal examination and the second PSA test is therefore undertaken prior to biopsy in order to confirm the diagnosis and initiate treatment if required.”